Here, we demonstrate reversal of key features of the Rett syndrome phenotype following antibody blockade of SEMA4D as well as upregulation of SEMA4D expression during disease progression and the effects of SEMA4D on reactive transformation of mutant glial cells expressing the Plexin B1 receptor. This evidence concerns the gene SEMA4D and atypical Rett syndrome.